Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pavan Kavali

Vascular & Interventional Radiology Saint Louis, MO Medical Doctor

NPI 1609192277 CMS profile 1351986

510 S Kingshighway Blvd, Dept Radiology, Saint Louis, MO 63110

Open in the dashboard

General payments

$90,226

283 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pavan Kavali of Saint Louis, MO is reported in the CMS Open Payments database as having received $90,226 across 283 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $59,817 104
2024 General $15,375 66
2023 General $10,703 46
2022 General $1,493 28
2021 General $836 12
2020 General $696 6
2019 General $1,308 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pavan Kavali
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Pavan Kavali were reported at $59,817. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Pavan Kavali Vascular & Interventional Radiology median Middle half National median
2019 $1,308 $422 $125–$1,555 $163
2020 $696 $200 $68–$652 $114
2021 $836 $280 $99–$866 $132
2022 $1,493 $433 $137–$1,497 $149
2023 $10,703 $506 $152–$2,019 $160
2024 $15,375 $556 $175–$1,930 $164
2025 $59,817 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $53,808 112 payments
  2. Surmodics, Inc. $14,832 18 payments
  3. AngioDynamics, Inc. $13,268 23 payments
  4. Boston Scientific Corporation $3,273 63 payments
  5. Terumo Medical Corporation $1,588 20 payments
  6. Inari Medical, Inc. $1,488 22 payments
  7. Endovascular Engineering Inc. $500 1 payment
  8. Medtronic, Inc. $318 9 payments
  9. Thrombolex, Inc. $239 3 payments
  10. Sirtex Medical Inc $211 3 payments
  11. Other $702 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $31,800 10 payments
  2. Consulting Fee $21,900 6 payments
  3. Travel and Lodging $19,536 52 payments
  4. Food and Beverage $16,490 214 payments
  5. Honoraria $500 1 payment
Products named General payments · program years 2019–2025
  1. Indigo System $44,339 101 payments
  2. Pounce Venous Thrombectomy System $14,347 17 payments
  3. RUBY Coil $8,898 6 payments
  4. ALPHAVAC $7,135 16 payments
  5. ANGIOVAC $6,133 7 payments
  6. Pounce Thrombectomy $1,181 5 payments
  7. ClotTriever $1,048 14 payments
  8. FlowTriever $1,048 14 payments
  9. EMBOLD Fibered $793 13 payments
  10. FLOWTRIEVER CATHETER, S $728 11 payments
  11. Other $7,290 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 98 billing codes

Paid by Medicare

$37,903

Medicare's payments for the services billed

Medicare patients

165

Average age 68

Services billed

506

73 women, 92 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Chronic kidney disease 49%
Ischemic heart disease 47%
Diabetes 41%
Depression 36%
Heart failure 35%
Cancer 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

283 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record